PLYMOUTH
MEETING, Pa., July 25,
2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a
biotechnology company focused on developing and commercializing DNA
medicines to help treat and protect people from HPV-associated
diseases, cancer, and infectious diseases, today announced that
second quarter 2024 financial results will be released after the
market close on August 8, 2024.
Following the release, INOVIO will host a live conference call and
webcast at 4:30 p.m. ET to discuss
financial results and provide a general business update.
The live webcast will be available online at
http://ir.inovio.com/events-and-presentations/default.aspx. This is
a listen-only event but will include a live Q&A with analysts.
The webcast will be archived and available for replay for 90 days
following the event.
About INOVIO
INOVIO is a biotechnology company focused
on developing and commercializing DNA medicines to help treat and
protect people from HPV-related diseases, cancer, and infectious
diseases. INOVIO's technology optimizes the design and delivery of
innovative DNA medicines that teach the body to manufacture its own
disease-fighting tools. For more information, visit
www.inovio.com.
Contacts
Media: Jennie
Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267)
440-4298 thomas.hong@inovio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-second-quarter-2024-financial-results-on-august-8-2024-302206052.html
SOURCE INOVIO Pharmaceuticals, Inc.
